How silly I was to think that the RE was finally doing the right thing for investors.
The EM is a great example of the adage "the devil is in the detail": - no more distributions - redemptions...but only six monthly, and only starting Dec 2023 (!), and only for limited amounts - those limited amounts will be funded only when existing investments are liquidated in the normal course - but, not even all of that money will go towards funding withdrawals - they are going to use some of it to start making new investments!!! - ...and so the remaining fund that's buying all the others, CD3, will now continue in perpetuity, and the existing wind-down horizon on our shares will be completely lost
I can't see this being voted up. It's a sh!t sandwich. How can the RE, hand on heart, claim this is a good deal for anyone except for the RE?
CD3 Price at posting:
$1.48 Sentiment: Sell Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)